Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
Progression Of Macular Atrophy In Patients With Neovascular Age-Related Macular Degeneration Undergoing Antivascular Endothelial Growth Factor Therapy
Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials
Two-Year Outcomes of “Treat and Extend” Intravitreal Therapy for Neovascular Age-Related Macular Degeneration